JZYY(SH:600750) Xin Lang Cai Jing·2025-12-18 02:49Group 1 - The core viewpoint of the news is that Jiangzhong Pharmaceutical has shown a positive stock performance with a year-to-date increase of 15.86% and a recent uptick of 2.05% in its stock price [1][2] - As of December 18, the stock price reached 24.91 yuan per share, with a market capitalization of 15.817 billion yuan and a trading volume of 75.7848 million yuan [1] - The company's main business revenue composition includes over-the-counter drugs at 72.40%, prescription drugs at 16.81%, and health consumer products at 10.67% [2] Group 2 - For the period from January to September 2025, Jiangzhong Pharmaceutical reported a revenue of 2.933 billion yuan, a year-on-year decrease of 1.30%, while the net profit attributable to shareholders increased by 7.74% to 683 million yuan [2] - The company has distributed a total of 4.843 billion yuan in dividends since its A-share listing, with 2.304 billion yuan distributed in the last three years [3] - As of September 30, 2025, the number of shareholders increased by 7.29% to 41,900, while the average circulating shares per person decreased by 6.79% to 14,986 shares [2]